1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 United States Companion Diagnostics Market - Introduction
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence
5 United States Companion Diagnostics Market Landscape
5.1 Historical and Current Market Trends (2018-2023)
5.2 Market Forecast (2024-2032)
6 United States Companion Diagnostics Market - Breakup by Product & Service
6.1 Assays, Kits and Reagents
6.1.1 Overview
6.1.2 Historical and Current Market Trends (2018-2023)
6.1.3 Market Forecast (2024-2032)
6.2 Software and Services
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2018-2023)
6.2.3 Market Forecast (2024-2032)
7 United States Companion Diagnostics Market - Breakup by Technology
7.1 Immunohistochemistry (IHC)
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2018-2023)
7.1.3 Market Forecast (2024-2032)
7.2 Polymerase Chain Reaction (PCR)
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2018-2023)
7.2.3 Market Forecast (2024-2032)
7.3 In-situ Hybridization (ISH)
7.3.1 Overview
7.3.2 Historical and Current Market Trends (2018-2023)
7.3.3 Market Forecast (2024-2032)
7.4 Real-time PCR (RT-PCR)
7.4.1 Overview
7.4.2 Historical and Current Market Trends (2018-2023)
7.4.3 Market Forecast (2024-2032)
7.5 Gene Sequencing
7.5.1 Overview
7.5.2 Historical and Current Market Trends (2018-2023)
7.5.3 Market Forecast (2024-2032)
7.6 Others
7.6.1 Historical and Current Market Trends (2018-2023)
7.6.2 Market Forecast (2024-2032)
8 United States Companion Diagnostics Market - Breakup by Indication
8.1 Cancer
8.1.1 Overview
8.1.2 Historical and Current Market Trends (2018-2023)
8.1.3 Market Segmentation
8.1.3.1 Lung Cancer
8.1.3.2 Breast Cancer
8.1.3.3 Colorectal Cancer
8.1.3.4 Gastric Cancer
8.1.3.5 Melanoma
8.1.3.6 Others
8.1.4 Market Forecast (2024-2032)
8.2 Neurological Diseases
8.2.1 Overview
8.2.2 Historical and Current Market Trends (2018-2023)
8.2.3 Market Forecast (2024-2032)
8.3 Infectious Diseases
8.3.1 Overview
8.3.2 Historical and Current Market Trends (2018-2023)
8.3.3 Market Forecast (2024-2032)
8.4 Cardiovascular Diseases
8.4.1 Overview
8.4.2 Historical and Current Market Trends (2018-2023)
8.4.3 Market Forecast (2024-2032)
8.5 Others
8.5.1 Historical and Current Market Trends (2018-2023)
8.5.2 Market Forecast (2024-2032)
9 United States Companion Diagnostics Market - Breakup by End User
9.1 Pharmaceutical & Biopharmaceutical Companies
9.1.1 Overview
9.1.2 Historical and Current Market Trends (2018-2023)
9.1.3 Market Forecast (2024-2032)
9.2 Reference Laboratories
9.2.1 Overview
9.2.2 Historical and Current Market Trends (2018-2023)
9.2.3 Market Forecast (2024-2032)
9.3 Contract Research Organizations
9.3.1 Overview
9.3.2 Historical and Current Market Trends (2018-2023)
9.3.3 Market Forecast (2024-2032)
9.4 Others
9.4.1 Historical and Current Market Trends (2018-2023)
9.4.2 Market Forecast (2024-2032)
10 United States Companion Diagnostics Market – Breakup by Region
10.1 Northeast
10.1.1 Overview
10.1.2 Historical and Current Market Trends (2018-2023)
10.1.3 Market Breakup by Product & Service
10.1.4 Market Breakup by Technology
10.1.5 Market Breakup by Indication
10.1.6 Market Breakup by End User
10.1.7 Key Players
10.1.8 Market Forecast (2024-2032)
10.2 Midwest
10.2.1 Overview
10.2.2 Historical and Current Market Trends (2018-2023)
10.2.3 Market Breakup by Product & Service
10.2.4 Market Breakup by Technology
10.2.5 Market Breakup by Indication
10.2.6 Market Breakup by End User
10.2.7 Key Players
10.2.8 Market Forecast (2024-2032)
10.3 South
10.3.1 Overview
10.3.2 Historical and Current Market Trends (2018-2023)
10.3.3 Market Breakup by Product & Service
10.3.4 Market Breakup by Technology
10.3.5 Market Breakup by Indication
10.3.6 Market Breakup by End User
10.3.7 Key Players
10.3.8 Market Forecast (2024-2032)
10.4 West
10.4.1 Overview
10.4.2 Historical and Current Market Trends (2018-2023)
10.4.3 Market Breakup by Product & Service
10.4.4 Market Breakup by Technology
10.4.5 Market Breakup by Indication
10.4.6 Market Breakup by End User
10.4.7 Key Players
10.4.8 Market Forecast (2024-2032)
11 United States Companion Diagnostics Market – Competitive Landscape
11.1 Overview
11.2 Market Structure
11.3 Market Player Positioning
11.4 Top Winning Strategies
11.5 Competitive Dashboard
11.6 Company Evaluation Quadrant
12 Profiles of Key Players
12.1 Company A
12.1.1 Business Overview
12.1.2 Product Portfolio
12.1.3 Business Strategies
12.1.4 SWOT Analysis
12.1.5 Major News and Events
12.2 Company B
12.2.1 Business Overview
12.2.2 Product Portfolio
12.2.3 Business Strategies
12.2.4 SWOT Analysis
12.2.5 Major News and Events
12.3 Company C
12.3.1 Business Overview
12.3.2 Product Portfolio
12.3.3 Business Strategies
12.3.4 SWOT Analysis
12.3.5 Major News and Events
12.4 Company D
12.4.1 Business Overview
12.4.2 Product Portfolio
12.4.3 Business Strategies
12.4.4 SWOT Analysis
12.4.5 Major News and Events
12.5 Company E
12.5.1 Business Overview
12.5.2 Product Portfolio
12.5.3 Business Strategies
12.5.4 SWOT Analysis
12.5.5 Major News and Events
Company names have not been provided here as this is a sample TOC. The complete list is provided in the report.
13 United States Companion Diagnostics Market - Industry Analysis
13.1 Drivers, Restraints, and Opportunities
13.1.1 Overview
13.1.2 Drivers
13.1.3 Restraints
13.1.4 Opportunities
13.2 Porters Five Forces Analysis
13.2.1 Overview
13.2.2 Bargaining Power of Buyers
13.2.3 Bargaining Power of Suppliers
13.2.4 Degree of Competition
13.2.5 Threat of New Entrants
13.2.6 Threat of Substitutes
13.3 Value Chain Analysis
14 Appendix